Comparison of 2,17-dimethyl testosterone and fluoxymesterone in metastatic breast cancer. Nonprogression--an index of tumor therapy evaluation. [electronic resource]
- Cancer Apr 1963
- 440-3 p. digital
Publication Type: Journal Article
0008-543X
10.1002/1097-0142(196304)16:4<440::aid-cncr2820160404>3.0.co;2-g doi
Anatomy Antineoplastic Agents Breast Neoplasms Fluoxymesterone Humans Methyltestosterone